开发一个决策支持工具来指导双相抑郁症治疗的共同决策:临床医生和有生活经验的人之间合作的结果。

IF 5 2区 医学 Q1 CLINICAL NEUROLOGY
Manuel Fuentes-Salgado, Manuel Gardea-Resendez, Andrew Smith, Angie Lam, Kimberly Allen, Mete Ercis, Ashley Kremin, Jeremiah B Joyce, Jin Hong Park, Nicola Keeth, Katherine Moore, Hannah Betcher, Padao Yang, Jonathan G Leung, Aysegul Ozerdem, Samuel T Savitz, Mark D Williams, Victor M Montori, Pollock Michael, Mark A Frye
{"title":"开发一个决策支持工具来指导双相抑郁症治疗的共同决策:临床医生和有生活经验的人之间合作的结果。","authors":"Manuel Fuentes-Salgado, Manuel Gardea-Resendez, Andrew Smith, Angie Lam, Kimberly Allen, Mete Ercis, Ashley Kremin, Jeremiah B Joyce, Jin Hong Park, Nicola Keeth, Katherine Moore, Hannah Betcher, Padao Yang, Jonathan G Leung, Aysegul Ozerdem, Samuel T Savitz, Mark D Williams, Victor M Montori, Pollock Michael, Mark A Frye","doi":"10.1111/bdi.70037","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To build consensus from different stakeholders on the content and digital interactivity of a shared decision making (SDM) tool to guide patient-clinician collaborative conversations about treatment for bipolar depression.</p><p><strong>Patients and methods: </strong>This study was conducted between September 2022 and September 2023. In the first phase, we conducted a narrative review on pharmacological, neuromodulatory, and psychotherapeutic treatments available for bipolar depression. For each option, we assessed treatment effectiveness, side effects, need for clinical monitoring, clinical considerations, and cost. In the second phase, committees comprised of mental health clinicians and people with lived experience with bipolar disorder from a national mood disorders advocacy group identified key features and content to be included in the SDM tool. A thematic analysis of these data then contributed to populate the SDM tool.</p><p><strong>Results: </strong>Twenty-one evidence-based treatment options identified from the narrative review were presented to the four convened committees (clinical, lived experience, peer council, and integrated steering committees) in five meetings. After discussions and thematic analysis, 12 outcomes of interest for each of the therapeutic interventions were delineated for inclusion in a web-based SDM tool. A detailed description of the development process and SDM tool is provided.</p><p><strong>Conclusion: </strong>This is the first partnership between clinicians and persons with bipolar disorder lived experience charged with the development of a patient-centered SDM tool to integrate clinical evidence with real-world clinical practice and patient preferences for use during clinical encounters. Human-centered design and testing in real clinical encounters will now contribute to refining the instrument and readying it for rigorous evaluation and implementation in practice.</p>","PeriodicalId":8959,"journal":{"name":"Bipolar Disorders","volume":" ","pages":""},"PeriodicalIF":5.0000,"publicationDate":"2025-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Developing a Decision Support Tool to Guide Shared Decision-Making in Bipolar Depression Treatment: Results From a Collaboration Between Clinicians and People With Lived Experience.\",\"authors\":\"Manuel Fuentes-Salgado, Manuel Gardea-Resendez, Andrew Smith, Angie Lam, Kimberly Allen, Mete Ercis, Ashley Kremin, Jeremiah B Joyce, Jin Hong Park, Nicola Keeth, Katherine Moore, Hannah Betcher, Padao Yang, Jonathan G Leung, Aysegul Ozerdem, Samuel T Savitz, Mark D Williams, Victor M Montori, Pollock Michael, Mark A Frye\",\"doi\":\"10.1111/bdi.70037\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>To build consensus from different stakeholders on the content and digital interactivity of a shared decision making (SDM) tool to guide patient-clinician collaborative conversations about treatment for bipolar depression.</p><p><strong>Patients and methods: </strong>This study was conducted between September 2022 and September 2023. In the first phase, we conducted a narrative review on pharmacological, neuromodulatory, and psychotherapeutic treatments available for bipolar depression. For each option, we assessed treatment effectiveness, side effects, need for clinical monitoring, clinical considerations, and cost. In the second phase, committees comprised of mental health clinicians and people with lived experience with bipolar disorder from a national mood disorders advocacy group identified key features and content to be included in the SDM tool. A thematic analysis of these data then contributed to populate the SDM tool.</p><p><strong>Results: </strong>Twenty-one evidence-based treatment options identified from the narrative review were presented to the four convened committees (clinical, lived experience, peer council, and integrated steering committees) in five meetings. After discussions and thematic analysis, 12 outcomes of interest for each of the therapeutic interventions were delineated for inclusion in a web-based SDM tool. A detailed description of the development process and SDM tool is provided.</p><p><strong>Conclusion: </strong>This is the first partnership between clinicians and persons with bipolar disorder lived experience charged with the development of a patient-centered SDM tool to integrate clinical evidence with real-world clinical practice and patient preferences for use during clinical encounters. Human-centered design and testing in real clinical encounters will now contribute to refining the instrument and readying it for rigorous evaluation and implementation in practice.</p>\",\"PeriodicalId\":8959,\"journal\":{\"name\":\"Bipolar Disorders\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":5.0000,\"publicationDate\":\"2025-06-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Bipolar Disorders\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/bdi.70037\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bipolar Disorders","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/bdi.70037","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的:建立不同利益相关者对共享决策(SDM)工具的内容和数字交互性的共识,以指导双相抑郁症治疗的患者-临床协作对话。患者和方法:本研究于2022年9月至2023年9月进行。在第一阶段,我们对双相抑郁症的药理学、神经调节和心理治疗方法进行了叙述性回顾。对于每种选择,我们评估了治疗效果、副作用、临床监测的必要性、临床考虑因素和成本。在第二阶段,由心理健康临床医生和来自全国情绪障碍倡导小组的有双相情感障碍生活经验的人组成的委员会确定了SDM工具要包括的关键特征和内容。然后对这些数据进行专题分析,以填充SDM工具。结果:从叙述性综述中确定的21种循证治疗方案在5次会议上提交给4个召集委员会(临床、生活经验、同行委员会和综合指导委员会)。经过讨论和专题分析,每种治疗干预措施的12个相关结果被纳入基于网络的SDM工具。详细介绍了开发过程和SDM工具。结论:这是临床医生和双相情感障碍患者之间的第一次合作,负责开发以患者为中心的SDM工具,将临床证据与现实世界的临床实践和患者在临床遇到时的使用偏好相结合。以人为本的设计和在实际临床接触中的测试现在将有助于改进该仪器,并为在实践中进行严格的评估和实施做好准备。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Developing a Decision Support Tool to Guide Shared Decision-Making in Bipolar Depression Treatment: Results From a Collaboration Between Clinicians and People With Lived Experience.

Objective: To build consensus from different stakeholders on the content and digital interactivity of a shared decision making (SDM) tool to guide patient-clinician collaborative conversations about treatment for bipolar depression.

Patients and methods: This study was conducted between September 2022 and September 2023. In the first phase, we conducted a narrative review on pharmacological, neuromodulatory, and psychotherapeutic treatments available for bipolar depression. For each option, we assessed treatment effectiveness, side effects, need for clinical monitoring, clinical considerations, and cost. In the second phase, committees comprised of mental health clinicians and people with lived experience with bipolar disorder from a national mood disorders advocacy group identified key features and content to be included in the SDM tool. A thematic analysis of these data then contributed to populate the SDM tool.

Results: Twenty-one evidence-based treatment options identified from the narrative review were presented to the four convened committees (clinical, lived experience, peer council, and integrated steering committees) in five meetings. After discussions and thematic analysis, 12 outcomes of interest for each of the therapeutic interventions were delineated for inclusion in a web-based SDM tool. A detailed description of the development process and SDM tool is provided.

Conclusion: This is the first partnership between clinicians and persons with bipolar disorder lived experience charged with the development of a patient-centered SDM tool to integrate clinical evidence with real-world clinical practice and patient preferences for use during clinical encounters. Human-centered design and testing in real clinical encounters will now contribute to refining the instrument and readying it for rigorous evaluation and implementation in practice.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Bipolar Disorders
Bipolar Disorders 医学-精神病学
CiteScore
8.20
自引率
7.40%
发文量
90
审稿时长
6-12 weeks
期刊介绍: Bipolar Disorders is an international journal that publishes all research of relevance for the basic mechanisms, clinical aspects, or treatment of bipolar disorders and related illnesses. It intends to provide a single international outlet for new research in this area and covers research in the following areas: biochemistry physiology neuropsychopharmacology neuroanatomy neuropathology genetics brain imaging epidemiology phenomenology clinical aspects and therapeutics of bipolar disorders Bipolar Disorders also contains papers that form the development of new therapeutic strategies for these disorders as well as papers on the topics of schizoaffective disorders, and depressive disorders as these can be cyclic disorders with areas of overlap with bipolar disorders. The journal will consider for publication submissions within the domain of: Perspectives, Research Articles, Correspondence, Clinical Corner, and Reflections. Within these there are a number of types of articles: invited editorials, debates, review articles, original articles, commentaries, letters to the editors, clinical conundrums, clinical curiosities, clinical care, and musings.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信